Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse
Authors:
- Joseph A. VetroJoseph A. Vetro
- Shugo SuzukiSSShugo Suzuki
- Michelle L. VarneyMVMichelle L. Varney
- Huai-Yun HanHHHuai-Yun Han
- Merielen NascimentoMNMerielen Nascimento
- Karen L. PenningtonKPKaren L. Pennington
- Lora L. ArnoldLALora L. Arnold
- Rakesh K. SinghRSRakesh K. Singh
- Samuel M. CohenSCSamuel M. Cohen
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 237 (1) , 83-90
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Selective Activation of Peroxisome Proliferator–Activated Receptor (PPAR)α and PPARγ Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor–Dependent MechanismDiabetes, 2008
- Comparison of Endothelial Cell Proliferation in Normal Liver and Adipose Tissue in B6C3F1 Mice, F344 Rats, and HumansToxicologic Pathology, 2007
- The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARαToxicological Sciences, 2007
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPARγ-independent mannerProstaglandins & Other Lipid Mediators, 2001
- Spontaneous and Thiazolidinedione-Induced B6C3F1 Mouse Hemangiosarcomas Exhibit Low ras Oncogene Mutation FrequenciesToxicology and Applied Pharmacology, 1999
- p53 Is Not Inactivated in B6C3F1 Mouse Vascular Tumors Arising Spontaneously or Associated with Long-Term Administration of the Thiazolidinedione TroglitazoneToxicology and Applied Pharmacology, 1999
- Clinical Pharmacokinetics of TroglitazoneClinical Pharmacokinetics, 1999
- Expression of Peroxisome Proliferator Activated Receptor mRNA in Normal and Tumorigenic Rodent Mammary GlandsBiochemical and Biophysical Research Communications, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998